Form 4: Willard Dere Acquires 78,636 Stock Options in Metagenomi, Inc.
SEC Form 4 Filing
Director Willard H Dere acquired 78,636 stock options in Metagenomi, Inc. on April 1, 2024, according to a Form 4 filing with the SEC.
Summary
- Willard H Dere, a director of Metagenomi, Inc., acquired 78,636 stock options on April 1, 2024.
- The exercise price of these options is $10.82.
- The options vest over time, with 33.33% vesting on April 1, 2025, and the remainder vesting in 24 equal monthly installments thereafter, contingent upon continued service with the issuer.
- Following the transaction, Dere directly owns 78,636 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants, which is neither particularly positive nor negative on its own.
Positives
- The acquisition of stock options by a director signals confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to executive compensation and insider transactions, common in publicly traded companies.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment as it indicates a director's belief in the company's future.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of transaction: acquisition of stock options. |
| 04/01/2025 | First vesting date for 33.33% of the stock options. |
| 03/31/2034 | Expiration date of the stock options. |
| 04/03/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.